BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Metabolic Solutions Development Company 

125 South Kalamazoo Mall
Suite 202
Kalamazoo  Michigan  49007  U.S.A.
Phone: 616-464-5071 Fax: 616-940-6223


SEARCH JOBS





Segment
Start Up





 Company News
Metabolic Solutions Development Company Presents Phase 2a Clinical Trial Results at the 14th International Conference on Alzheimer's Drug Discovery 9/9/2013 8:02:12 AM
Metabolic Solutions Development Company Announces Publication of Data Describing Potential for New Drugs to Maintain Pancreatic Beta-Cells in Treating Diabetes 5/30/2013 9:28:00 AM
Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation 2/7/2013 9:54:50 AM
Metabolic Solutions Development Company Announces Publication of Phase 2b Data in Clinical Pharmacology & Therapeutics 1/25/2013 6:00:14 AM
Metabolic Solutions Development Company Receives $1.1 Million National Institutes of Health (NIH) Grant to Further Investigate MSDC-0602 for the Treatment of Fatty Liver Disease 10/7/2011 2:00:37 PM
Metabolic Solutions Development Company Presents New Brown Fat Research at the European Association for the Study of Diabetes 9/13/2011 12:03:23 PM
Metabolic Solutions Development Company Reports Positive Top-Line Results From Phase 2a Study of its Second Compound to Treat Type 2 Diabetes 9/9/2011 6:44:01 AM
Metabolic Solutions Development Company Raises Another $6.8 Million 8/16/2011 7:06:38 AM
Metabolic Solutions Development Company Receives $773,000 From the Alzheimer's Drug Discovery Foundation to Fund Phase 2a Trial 7/6/2011 9:05:36 AM
Metabolic Solutions Development Company to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference 6/21/2011 8:43:56 AM
12